Literature DB >> 7652925

A novel series of P2T purinoceptor antagonists: definition of the role of ADP in arterial thrombosis.

R G Humphries1, M J Robertson, P Leff.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7652925     DOI: 10.1016/s0165-6147(00)89018-5

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN: 0165-6147            Impact factor:   14.819


× No keyword cloud information.
  11 in total

Review 1.  New thrombolytics, anticoagulants, and platelet antagonists: the future of clinical practice.

Authors:  R C Becker
Journal:  J Thromb Thrombolysis       Date:  1999-04       Impact factor: 2.300

2.  Differential effects of adenine nucleotide analogues on shape change and aggregation induced by adnosine 5-diphosphate (ADP) in human platelets.

Authors:  H S Park; S M Hourani
Journal:  Br J Pharmacol       Date:  1999-07       Impact factor: 8.739

Review 3.  P2 receptor subtypes in the cardiovascular system.

Authors:  S P Kunapuli; J L Daniel
Journal:  Biochem J       Date:  1998-12-15       Impact factor: 3.857

4.  Antiplatelet therapy. Cangrelor succeeds, at last, in PCI.

Authors:  Robert F Storey
Journal:  Nat Rev Cardiol       Date:  2013-04-23       Impact factor: 32.419

Review 5.  Pharmacology of the new P2Y12 receptor inhibitors: insights on pharmacokinetic and pharmacodynamic properties.

Authors:  Nicola Ferri; Alberto Corsini; Stefano Bellosta
Journal:  Drugs       Date:  2013-10       Impact factor: 9.546

6.  P1,P4-dithio-P2,P3-monochloromethylene diadenosine 5',5'''-P1,P4-tetraphosphate: a novel antiplatelet agent.

Authors:  S W Chan; S J Gallo; B K Kim; M J Guo; G M Blackburn; P C Zamecnik
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-15       Impact factor: 11.205

7.  Pharmacological characterization of the human P2Y11 receptor.

Authors:  D Communi; B Robaye; J M Boeynaems
Journal:  Br J Pharmacol       Date:  1999-11       Impact factor: 8.739

8.  P2-Purinoceptors: Advances and therapeutic opportunities.

Authors:  Michael Williams; Kenneth A Jacobson
Journal:  Expert Opin Investig Drugs       Date:  1995-10       Impact factor: 6.206

9.  The C6-2B glioma cell P2Y(AC) receptor is pharmacologically and molecularly identical to the platelet P2Y(12) receptor.

Authors:  J Jin; W Tomlinson; I P Kirk; Y B Kim; R G Humphries; S P Kunapuli
Journal:  Br J Pharmacol       Date:  2001-06       Impact factor: 8.739

10.  Coactivation of two different G protein-coupled receptors is essential for ADP-induced platelet aggregation.

Authors:  J Jin; S P Kunapuli
Journal:  Proc Natl Acad Sci U S A       Date:  1998-07-07       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.